Hits and Misses in Novel Pancreatic and Rectal Cancer Treatment Options

Michael D Chuong¹, Christopher J Anker², Michael H Buckstein³, Maria A Hawkins⁴, Jordan Kharofa⁵, Ann C Raldow⁶, Nina N Sanford⁷, Andrzej Wojcieszysnki⁸, Jeffrey R Olsen⁹

Affiliations

¹ Department of Radiation Oncology, Miami Cancer Institute, Miami, Florida.
² Division of Radiation Oncology, University of Vermont Larner College of Medicine, Burlington, Vermont.
³ Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
⁴ University College London, London, United Kingdom.
⁵ Department of Radiation Oncology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
⁶ Department of Radiation Oncology, University of California, Los Angeles, California.
⁷ Department of Radiation Oncology, University of Texas Southwestern, Dallas, Texas.
⁸ Kaiser Permanente Medical Group, Denver, Colorado.
⁹ Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado. Electronic address: Jeffrey.R.Olsen@CUAnschutz.edu.

PMID: 36725162
DOI: 10.1016/j.ijrobp.2022.10.022

Editorial

Hits and Misses in Novel Pancreatic and Rectal Cancer Treatment Options

Michael D Chuong et al. Int J Radiat Oncol Biol Phys. 2023.

. 2023 Mar 1;115(3):545-552.

doi: 10.1016/j.ijrobp.2022.10.022.

Authors

Michael D Chuong¹, Christopher J Anker², Michael H Buckstein³, Maria A Hawkins⁴, Jordan Kharofa⁵, Ann C Raldow⁶, Nina N Sanford⁷, Andrzej Wojcieszysnki⁸, Jeffrey R Olsen⁹

Affiliations

¹ Department of Radiation Oncology, Miami Cancer Institute, Miami, Florida.
² Division of Radiation Oncology, University of Vermont Larner College of Medicine, Burlington, Vermont.
³ Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
⁴ University College London, London, United Kingdom.
⁵ Department of Radiation Oncology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
⁶ Department of Radiation Oncology, University of California, Los Angeles, California.
⁷ Department of Radiation Oncology, University of Texas Southwestern, Dallas, Texas.
⁸ Kaiser Permanente Medical Group, Denver, Colorado.
⁹ Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado. Electronic address: Jeffrey.R.Olsen@CUAnschutz.edu.

PMID: 36725162
DOI: 10.1016/j.ijrobp.2022.10.022

Erratum in

Erratum to: Chuong MD, Anker CJ, Buckstein MH, et al. Hits and misses in novel pancreatic and rectal cancer treatment options. Int J Radiat Oncol Biol Phys 2023;115:545-552.
[No authors listed] [No authors listed] Int J Radiat Oncol Biol Phys. 2023 Dec 1;117(5):1302. doi: 10.1016/j.ijrobp.2023.08.004. Epub 2023 Aug 14. Int J Radiat Oncol Biol Phys. 2023. PMID: 37578415 No abstract available.

No abstract available

PubMed Disclaimer

Comment on

Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial.
Versteijne E, van Dam JL, Suker M, Janssen QP, Groothuis K, Akkermans-Vogelaar JM, Besselink MG, Bonsing BA, Buijsen J, Busch OR, Creemers GM, van Dam RM, Eskens FALM, Festen S, de Groot JWB, Groot Koerkamp B, de Hingh IH, Homs MYV, van Hooft JE, Kerver ED, Luelmo SAC, Neelis KJ, Nuyttens J, Paardekooper GMRM, Patijn GA, van der Sangen MJC, de Vos-Geelen J, Wilmink JW, Zwinderman AH, Punt CJ, van Tienhoven G, van Eijck CHJ; Dutch Pancreatic Cancer Group. Versteijne E, et al. J Clin Oncol. 2022 Apr 10;40(11):1220-1230. doi: 10.1200/JCO.21.02233. Epub 2022 Jan 27. J Clin Oncol. 2022. PMID: 35084987 Clinical Trial.
Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC).
Chen IM, Johansen JS, Theile S, Hjaltelin JX, Novitski SI, Brunak S, Hasselby JP, Willemoe GL, Lorentzen T, Madsen K, Jensen BV, Wilken EE, Geertsen P, Behrens C, Nolsoe C, Hermann KL, Svane IM, Nielsen D. Chen IM, et al. J Clin Oncol. 2022 Sep 20;40(27):3180-3189. doi: 10.1200/JCO.21.02511. Epub 2022 Apr 27. J Clin Oncol. 2022. PMID: 35476508 Clinical Trial.
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy.
Garcia-Aguilar J, Patil S, Gollub MJ, Kim JK, Yuval JB, Thompson HM, Verheij FS, Omer DM, Lee M, Dunne RF, Marcet J, Cataldo P, Polite B, Herzig DO, Liska D, Oommen S, Friel CM, Ternent C, Coveler AL, Hunt S, Gregory A, Varma MG, Bello BL, Carmichael JC, Krauss J, Gleisner A, Paty PB, Weiser MR, Nash GM, Pappou E, Guillem JG, Temple L, Wei IH, Widmar M, Lin S, Segal NH, Cercek A, Yaeger R, Smith JJ, Goodman KA, Wu AJ, Saltz LB. Garcia-Aguilar J, et al. J Clin Oncol. 2022 Aug 10;40(23):2546-2556. doi: 10.1200/JCO.22.00032. Epub 2022 Apr 28. J Clin Oncol. 2022. PMID: 35483010 Free PMC article. Clinical Trial.
PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.
Cercek A, Lumish M, Sinopoli J, Weiss J, Shia J, Lamendola-Essel M, El Dika IH, Segal N, Shcherba M, Sugarman R, Stadler Z, Yaeger R, Smith JJ, Rousseau B, Argiles G, Patel M, Desai A, Saltz LB, Widmar M, Iyer K, Zhang J, Gianino N, Crane C, Romesser PB, Pappou EP, Paty P, Garcia-Aguilar J, Gonen M, Gollub M, Weiser MR, Schalper KA, Diaz LA Jr. Cercek A, et al. N Engl J Med. 2022 Jun 23;386(25):2363-2376. doi: 10.1056/NEJMoa2201445. Epub 2022 Jun 5. N Engl J Med. 2022. PMID: 35660797 Free PMC article. Clinical Trial.
Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial.
Katz MHG, Shi Q, Meyers J, Herman JM, Chuong M, Wolpin BM, Ahmad S, Marsh R, Schwartz L, Behr S, Frankel WL, Collisson E, Leenstra J, Williams TM, Vaccaro G, Venook A, Meyerhardt JA, O'Reilly EM. Katz MHG, et al. JAMA Oncol. 2022 Sep 1;8(9):1263-1270. doi: 10.1001/jamaoncol.2022.2319. JAMA Oncol. 2022. PMID: 35834226 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Hits and Misses in Novel Pancreatic and Rectal Cancer Treatment Options

Affiliations

Hits and Misses in Novel Pancreatic and Rectal Cancer Treatment Options

Authors

Affiliations

Erratum in

Comment on

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources